search
Back to results

Implementing and Sustaining a Sleep Treatment to Improve Community Mental Health Part 2: Train-the-Trainer

Primary Purpose

Sleep Disorder, Circadian Dysregulation

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Standard Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C)
Adapted Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C)
Usual Care Delayed Treatment
Sponsored by
University of California, Berkeley
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Sleep Disorder

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: The inclusion criteria for the CMHC local trainers are: Employed in participating CMHCs Completed a Generation 1 TranS-C training (i.e., led by UC Berkeley expert trainers) Volunteer to participate and formally consent to participate The inclusion criteria for CMHCs are: Publicly funded adult mental health outpatient services Support from CMHC leadership The inclusion criteria for CMHC providers are: Employed or able to deliver client-facing services to CMHC clients Interest in learning and delivering TranS-C Volunteer to participate and formally consent to participate Consumers must meet the following inclusion criteria: Aged 18 years and older Meet criteria for an SMI per self-report and confirmed by referring provider or administration of the Mini International Neuropsychiatric Interview (MINI) (DSM-5, Version 7.0.0) by a licensed clinical social worker on the research team Exhibit a sleep or circadian disturbance as determined by endorsing 4 "quite a bit" or 5 "very much" (or the equivalent for reverse scored items) on one or more PROMIS-SD questions Receiving the standard of care for the SMI and consent to regular communications between the research team and provider Consent to access their medical record and participate in assessments Guaranteed place to sleep for at least 2 months that is not a shelter Exclusion Criteria: Presence of an active and progressive physical illness or neurological degenerative disease directly related to the onset and course of the sleep and circadian dysfunction, or making participation in the study unfeasible based on confirmation from the treating clinician and/or medical record Presence of substance abuse/dependence only if it makes participation in the study unfeasible Current active intent or plan to commit suicide (those with suicidal ideation are eligible) only if it makes participation in the study unfeasible, or homicide risk Night shift work >2 nights per week in the past 3 months Pregnancy or breast-feeding

Sites / Locations

  • Contra Costa Health, Housing, and Homeless Services DivisionRecruiting
  • Solano County Department of Health & Social Services, Behavioral Health ServicesRecruiting
  • Kings County Behavioral HealthRecruiting
  • Lake County Behavioral Health ServicesRecruiting
  • Alameda County Behavioral Health Care ServicesRecruiting
  • Placer County Health and Human Services, Adult System of CareRecruiting
  • Monterey County Behavioral HealthRecruiting
  • Bay Area Community HealthRecruiting
  • County of Santa Cruz Behavioral Health Services for Children and AdultsRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Active Comparator

Arm Label

Standard TranS-C

Adapted TranS-C

UC-DT

Arm Description

Standard TranS-C is modularized and delivered across eight 50-minute, weekly, individual sessions. It is comprised of 4 cross-cutting interventions featured in every session; 4 core modules that apply to the vast majority of patients; and 7 optional modules used less commonly, depending on the presentation.

The process for developing Adapted TranS-C has been iterative and grounded in theory, data and stakeholder feedback. The core elements of the evidence-based theory of change underpinning TranS-C have been retained. Adapted TranS-C is delivered in four 20-minute, weekly, individual sessions.

Usual Care Delayed Treatment. Usual care in the partner CMHCs starts with a case manager who co-ordinates care and refers each client for a medication review and to various rehabilitation programs (e.g., health care, housing, nutrition, finding a job, peer monitoring).

Outcomes

Primary Outcome Measures

Patient-level outcome: Patient-Reported Outcomes Measurement Information System - Sleep Disturbance
Assesses perceived functional impairments related to sleep problems using a self-report questionnaire. The minimum value is 8. The maximum value is 40. Higher scores mean more sleep disturbance (worse outcome).
Provider-level outcome: Acceptability Intervention Measure
Assesses provider perceptions of the appropriateness of the treatment intervention using a self-report questionnaire and provider feedback.

Secondary Outcome Measures

Patient-level outcome: Patient-Reported Outcomes Measurement Information System - Sleep Related Impairment
Assesses perceived functional impairments related to sleep problems in a self-report questionnaire. The minimum value is 16. The maximum value is 80. Higher scores mean more sleep related problems (worse outcome).
Patient-level outcome: Composite Sleep Health Score
Composite Sleep Health Score which is defined as the sum of scores on 6 sleep health dimensions: Regularity (Midpoint fluctuation), Satisfaction (Sleep quality question on PROMIS-SD), Alertness (Daytime sleepiness question on PROMIS-SRI), Timing (Mean midpoint), Efficiency (Sleep efficiency) and Duration (Total Sleep Time).
Patient-level outcome: Midpoint of Sleep Measure
Assesses circadian functioning by calculating the midpoint between falling asleep time and rise time.
Patient-level outcome: Sheehan Disability Scale
Assesses functional impairment on a scale from 0 to 30, where higher scores mean higher impairment.
Patient-level outcome: The Diagnostic and Statistical Manual of Mental Disorders Cross-Cutting Symptom Measure
Assesses disorder-focused psychiatric symptoms using a self-report questionnaire. Each item on the measure is rated on a 5-point scale (from 0-4), where higher scores indicate a higher frequency of psychiatric symptoms (worse outcome).
Provider-level outcome: Intervention Appropriateness Measure
Assesses provider perceptions of the appropriateness of the treatment intervention using a self-report questionnaire
Provider-level outcome: Feasibility of Intervention Measure
Assesses provider perceptions of the feasibility of the intervention using a self-report questionnaire.

Full Information

First Posted
March 10, 2023
Last Updated
May 11, 2023
Sponsor
University of California, Berkeley
search

1. Study Identification

Unique Protocol Identification Number
NCT05805657
Brief Title
Implementing and Sustaining a Sleep Treatment to Improve Community Mental Health Part 2: Train-the-Trainer
Official Title
Implementing and Sustaining a Transdiagnostic Sleep and Circadian Treatment to Improve Severe Mental Illness Outcomes in Community Mental Health Part 2: Train-the-Trainer
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
December 14, 2020 (Actual)
Primary Completion Date
December 30, 2023 (Anticipated)
Study Completion Date
December 30, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of California, Berkeley

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The train-the-trainer (TTT) approach is a promising method of sustaining training efforts in community mental health centers (CMHCs). This study will test the implementation and effectiveness outcomes of a sleep treatment delivered by CMHC providers who are trained and supervised within CMHCs via TTT. The investigators will test two versions of the sleep treatment, a "Standard" version and an "Adapted" version that has been adapted using theory, data and stakeholder inputs to improve the fit for SMI patients treated in community mental health centers.
Detailed Description
There are significant barriers to widespread implementation and sustainment of evidence-based psychological treatments (EBPTs) in community mental health centers (CMHCs), including insufficient time and funding, shortage of trainers and consultants, and staff turnover. The investigators propose to evaluate one possible solution, the train-the-trainer (TTT) approach, in the context of a transdiagnostic EBPT for sleep and circadian dysfunction-the Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C)- for serious mental illness (SMI) in CMHCs. This entry describes the Train-the-Trainer Phase, the second of a three-phase hybrid type 2 effectiveness-implementation trial conducted to test TranS-C in CMHCs. TTT is a training structure with multiple levels, called "Generations." First, external expert trainers train an initial cohort of providers in a specific EBPT ("Generation 1 providers"). Next, Generation 1 providers are offered additional training in how to train others in the EBPT and become "local trainers." These local trainers then train the next cohort of providers within their organization ("Generation 2 providers"). The Train-the-Trainer Phase builds upon the first phase, the Implementation Phase (NCT04154631), in which implementation and effectiveness outcomes of two versions of TranS-C, Standard and Adapted are compared, with CMHC providers, who are trained by treatment experts. Adapted TranS-C is a version of TranS-C designed to improve 'fit' with the CMHC context. In the Train-the-Trainer Phase, the aim is to test implementation and effectiveness outcomes of Standard and Adapted TranS-C with CMHC providers who are trained and supervised within CMHCs (i.e., Generation 2 of TTT). In the Implementation Phase, 10 CMHC clinic sites were cluster randomized to either Standard or Adapted TranS-C. Nine CMHCs continued participation into the Train-the-Trainer Phase. Within each CMHC site, patients are randomized to immediate TranS-C or to Usual Care followed by Delayed Treatment (UC-DT). Generation 2 patients (n=130) will be assessed pre, mid and post-treatment and at 6 month follow-up. UC Berkeley will coordinate the research, facilitate implementation, collect data, etc. Generation 2 providers (n=60), trained by local trainers within an established network of CMHCs, will implement TranS-C and will be assessed at pre and post-treatment. SA1 is to confirm that both Standard vs. Adapted TranS-C, compared to UC-DT, improve sleep and circadian functioning and reduce functional impairment and disorder-focused psychiatric symptoms for Generation 2 patients. SA2 is to evaluate the fit, to the CMHC context, of Standard vs. Adapted TranS-C via Generation 2 provider ratings of acceptability, appropriateness and feasibility. SA3 will examine if better fit, operationalized via Generation 2 provider ratings of acceptability, mediates the relationship between treatment condition and Generation 2 patient outcome. This research will determine if (1) sleep and circadian problems can be effectively addressed in SMI by CMHC providers trained and supervised within CMHCs via the train-the-trainer approach, (2) test two variations of TranS-C that each have unique advantages and focus on community providers and typical community patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep Disorder, Circadian Dysregulation

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
CMHC sites will be cluster randomized to either Standard TranS-C or Adapted TranS-C. Then within each CMHC site, patients will be randomized to either TranS-C or to Usual Care followed by Delayed Treatment (UC-DT).
Masking
Outcomes Assessor
Masking Description
The assessment team will be blind to group allocation at post-treatment and six-month follow-up
Allocation
Randomized
Enrollment
190 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Standard TranS-C
Arm Type
Experimental
Arm Description
Standard TranS-C is modularized and delivered across eight 50-minute, weekly, individual sessions. It is comprised of 4 cross-cutting interventions featured in every session; 4 core modules that apply to the vast majority of patients; and 7 optional modules used less commonly, depending on the presentation.
Arm Title
Adapted TranS-C
Arm Type
Experimental
Arm Description
The process for developing Adapted TranS-C has been iterative and grounded in theory, data and stakeholder feedback. The core elements of the evidence-based theory of change underpinning TranS-C have been retained. Adapted TranS-C is delivered in four 20-minute, weekly, individual sessions.
Arm Title
UC-DT
Arm Type
Active Comparator
Arm Description
Usual Care Delayed Treatment. Usual care in the partner CMHCs starts with a case manager who co-ordinates care and refers each client for a medication review and to various rehabilitation programs (e.g., health care, housing, nutrition, finding a job, peer monitoring).
Intervention Type
Behavioral
Intervention Name(s)
Standard Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C)
Intervention Description
TranS-C is a psychosocial treatment designed to improve sleep and circadian functioning. It is a modular, psychosocial, skills-based approach. In this study, two version of TranS-C will be tested: Standard and Adapted.
Intervention Type
Behavioral
Intervention Name(s)
Adapted Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C)
Intervention Description
The Adapted version was derived from Standard TranS-C. It was developed to improve the fit of the treatment with the CMHC context.
Intervention Type
Other
Intervention Name(s)
Usual Care Delayed Treatment
Intervention Description
Usual care in the partner CMHCs typically starts with a case manager who co-ordinates care and refers each client for a medication review and to various rehabilitation programs (e.g., health care, housing, nutrition, finding a job, peer monitoring).
Primary Outcome Measure Information:
Title
Patient-level outcome: Patient-Reported Outcomes Measurement Information System - Sleep Disturbance
Description
Assesses perceived functional impairments related to sleep problems using a self-report questionnaire. The minimum value is 8. The maximum value is 40. Higher scores mean more sleep disturbance (worse outcome).
Time Frame
Change from baseline to post-treatment, which is 6 or 10 weeks after the beginning of treatment, and to 6-month follow-up.
Title
Provider-level outcome: Acceptability Intervention Measure
Description
Assesses provider perceptions of the appropriateness of the treatment intervention using a self-report questionnaire and provider feedback.
Time Frame
Change from baseline to post-treatment, which is 6 or 10 weeks after the beginning of treatment.
Secondary Outcome Measure Information:
Title
Patient-level outcome: Patient-Reported Outcomes Measurement Information System - Sleep Related Impairment
Description
Assesses perceived functional impairments related to sleep problems in a self-report questionnaire. The minimum value is 16. The maximum value is 80. Higher scores mean more sleep related problems (worse outcome).
Time Frame
Change from baseline, to mid-treatment, which is 2 or 4 weeks after the beginning of treatment, to post-treatment, which is 6 or 10 weeks after the beginning of treatment, and to 6-month follow-up.
Title
Patient-level outcome: Composite Sleep Health Score
Description
Composite Sleep Health Score which is defined as the sum of scores on 6 sleep health dimensions: Regularity (Midpoint fluctuation), Satisfaction (Sleep quality question on PROMIS-SD), Alertness (Daytime sleepiness question on PROMIS-SRI), Timing (Mean midpoint), Efficiency (Sleep efficiency) and Duration (Total Sleep Time).
Time Frame
Change from baseline, to mid-treatment, which is 2 or 4 weeks after the beginning of treatment, to post-treatment, which is 6 or 10 weeks after the beginning of treatment, and to 6-month follow-up.
Title
Patient-level outcome: Midpoint of Sleep Measure
Description
Assesses circadian functioning by calculating the midpoint between falling asleep time and rise time.
Time Frame
Change from baseline, to mid-treatment, which is 2 or 4 weeks after the beginning of treatment, to post-treatment, which is 6 or 10 weeks after the beginning of treatment, and to 6-month follow-up.
Title
Patient-level outcome: Sheehan Disability Scale
Description
Assesses functional impairment on a scale from 0 to 30, where higher scores mean higher impairment.
Time Frame
Change from baseline to post-treatment, which is 6 or 10 weeks after the beginning of treatment, and to 6-month follow-up.
Title
Patient-level outcome: The Diagnostic and Statistical Manual of Mental Disorders Cross-Cutting Symptom Measure
Description
Assesses disorder-focused psychiatric symptoms using a self-report questionnaire. Each item on the measure is rated on a 5-point scale (from 0-4), where higher scores indicate a higher frequency of psychiatric symptoms (worse outcome).
Time Frame
Change from baseline to post-treatment, which is 6 or 10 weeks after the beginning of treatment, and to 6-month follow-up.
Title
Provider-level outcome: Intervention Appropriateness Measure
Description
Assesses provider perceptions of the appropriateness of the treatment intervention using a self-report questionnaire
Time Frame
Change from baseline, to mid-treatment, which is 2 or 4 weeks after the beginning of treatment for each client, and to post-treatment, which is 6 or 10 weeks after the beginning of treatment.
Title
Provider-level outcome: Feasibility of Intervention Measure
Description
Assesses provider perceptions of the feasibility of the intervention using a self-report questionnaire.
Time Frame
Change from baseline, to mid-treatment, which is 2 or 4 weeks after the beginning of treatment for each client, and to post-treatment, which is 6 or 10 weeks after the beginning of treatment.
Other Pre-specified Outcome Measures:
Title
Patient-level outcome: Alcohol Intake
Description
Assesses past 30-day quantity and frequency of alcohol intake using a self-report questionnaire.
Time Frame
Change from baseline to post-treatment, which is 6 or 10 weeks after the beginning of treatment, and to 6-month follow-up.
Title
Patient-level outcome: Substances Intake
Description
Assesses past 30-day frequency of substance use using a self-report questionnaire.
Time Frame
Change from baseline to post-treatment, which is 6 or 10 weeks after the beginning of treatment, and to 6-month follow-up.
Title
Patient-level outcome: Tobacco Intake
Description
Assesses past 30-day quantity and frequency of tobacco intake using a self-report questionnaire.
Time Frame
Change from baseline to post-treatment, which is 6 or 10 weeks after the beginning of treatment, and to 6-month follow-up.
Title
Patient-level outcome: Caffeine Intake
Description
Assesses past 30-day quantity and frequency of caffeine intake using a self-report questionnaire.
Time Frame
Change from baseline to post-treatment, which is 6 or 10 weeks after the beginning of treatment, and to 6-month follow-up.
Title
Patient-level outcome: Suicidal Ideation Questionnaire
Description
Assesses past 30-day suicidal ideation using a self-report questionnaire.
Time Frame
Change from baseline to post-treatment, which is 6 or 10 weeks after the beginning of treatment, and to 6-month follow-up.
Title
Patient-level outcome: Credibility Expectancy Questionnaire
Description
Measures the credibility and expectation of improvement from TranS-C. The questionnaire includes 4 items.
Time Frame
Once at post-treatment, which is 6 or 10 weeks after the beginning of treatment.
Title
Patient-level outcome: Utilization Questionnaire
Description
Measures the elements of TranS-C that are most used.
Time Frame
Once at post-treatment, which is 6 or 10 weeks after the beginning of treatment.
Title
Patient-level outcome: Utilization Questionnaire
Description
Measures the elements of TranS-C that are most used.
Time Frame
Once at 6-month follow-up after treatment ends.
Title
Patient-level outcome: Duke Checklist of Medical Conditions & Symptoms
Description
Assesses physical illness or neurological degenerative disease directly related to the onset and course of the sleep and circadian dysfunction.
Time Frame
Once at baseline.
Title
Provider-level outcome: Checklist of Modules Delivered
Description
Assesses which treatment modules were delivered by the providers using a self-report checklist.
Time Frame
Once at each session between patient and provider.
Title
Provider-level outcome: Adaptations to Evidence-Based Practices Scale
Description
Assesses ad hoc modifications the provider made to the treatment using a self-report questionnaire.
Time Frame
Once at post-treatment, which is 6 or 10 weeks after the beginning of treatment.
Title
Provider-level outcome: Use of TranS-C Assessment
Description
Assesses if providers continue to use TranS-C in a self-report questionnaire.
Time Frame
Once during the 1 year sustainment phase.
Title
Provider-level outcome: Session attendance and duration log
Description
Collect session date and duration (length of session).
Time Frame
Once at each session between patient and provider.
Title
Provider-level outcome: Training evaluation/knowledge test
Description
Provider evaluation of the training; provider knowledge of content covered in the training; provider willingness and confidence in delivering TranS-C.
Time Frame
Through the first 2.5 years of the study, an average of 4 per month
Title
Provider-level outcome: Gold Standard Training Elements
Description
Extent of gold standard training elements present in each training session, with respect to content and technique.
Time Frame
Through the first 2.5 years of the study, an average of 4 per month
Title
Provider-level outcome: Number of TranS-C Sessions
Description
Number of sessions delivered to each enrolled patient by each provider.
Time Frame
Once per patient at posttreatment, which is 6 or 10 weeks after the beginning of treatment
Title
Facilitator-level outcome: Implementation Log
Description
Weekly record of facilitator activities, amount of time per activity, county, year, type of communication, implementation strategies, target(s), intended outcome(s).
Time Frame
Up to 30 months
Title
Facilitator-level outcome: Meeting Log
Description
Weekly record of community meeting details as applicable, including: county, generation, level of contact (i.e., leadership, providers), type/modality of contact, length of meeting, number of attendees, recording, general description, standardized description, main presenter and role of UC Berkeley staff.
Time Frame
Up to 30 months
Title
Patient-level outcome: Patient-Reported Outcomes Measurement Information System - Sleep Disturbance
Description
Assesses perceived functional impairments related to sleep problems using a self-report questionnaire. The minimum value is 8. The maximum value is 40. Higher scores mean more sleep disturbance (worse outcome).
Time Frame
Change from baseline to mid-treatment, which is 2 or 4 weeks after the beginning of treatment
Title
Provider-level outcome: Acceptability Intervention Measure
Description
Assesses provider perceptions of the appropriateness of the treatment intervention using a self-report questionnaire and provider feedback.
Time Frame
Change from baseline to mid-treatment, which is 2 or 4 weeks after the beginning of treatment for each client

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: The inclusion criteria for the CMHC local trainers are: Employed in participating CMHCs Completed a Generation 1 TranS-C training (i.e., led by UC Berkeley expert trainers) Volunteer to participate and formally consent to participate The inclusion criteria for CMHCs are: Publicly funded adult mental health outpatient services Support from CMHC leadership The inclusion criteria for CMHC providers are: Employed or able to deliver client-facing services to CMHC clients Interest in learning and delivering TranS-C Volunteer to participate and formally consent to participate Consumers must meet the following inclusion criteria: Aged 18 years and older Meet criteria for an SMI per self-report and confirmed by referring provider or administration of the Mini International Neuropsychiatric Interview (MINI) (DSM-5, Version 7.0.0) by a licensed clinical social worker on the research team Exhibit a sleep or circadian disturbance as determined by endorsing 4 "quite a bit" or 5 "very much" (or the equivalent for reverse scored items) on one or more PROMIS-SD questions Receiving the standard of care for the SMI and consent to regular communications between the research team and provider Consent to access their medical record and participate in assessments Guaranteed place to sleep for at least 2 months that is not a shelter Exclusion Criteria: Presence of an active and progressive physical illness or neurological degenerative disease directly related to the onset and course of the sleep and circadian dysfunction, or making participation in the study unfeasible based on confirmation from the treating clinician and/or medical record Presence of substance abuse/dependence only if it makes participation in the study unfeasible Current active intent or plan to commit suicide (those with suicidal ideation are eligible) only if it makes participation in the study unfeasible, or homicide risk Night shift work >2 nights per week in the past 3 months Pregnancy or breast-feeding
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Julia Spencer, BA
Phone
(510) 643-3797
Email
juliamarie_s@berkeley.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Rafael Esteva, BA
Phone
(510) 643-3797
Email
rafael.esteva@berkeley.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Allison Harvey, PhD
Organizational Affiliation
University of California, Berkeley
Official's Role
Principal Investigator
Facility Information:
Facility Name
Contra Costa Health, Housing, and Homeless Services Division
City
Concord
State/Province
California
ZIP/Postal Code
94520
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Emma Agnew, MSW
Phone
510-643-3797
Email
emmagnew@berkeley.edu
Facility Name
Solano County Department of Health & Social Services, Behavioral Health Services
City
Fairfield
State/Province
California
ZIP/Postal Code
94533
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Emma Agnew, MSW
Phone
510-643-3797
Email
emmagnew@berkeley.edu
Facility Name
Kings County Behavioral Health
City
Hanford
State/Province
California
ZIP/Postal Code
93230
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Emma Agnew, MSW
Phone
510-643-3797
Email
emmagnew@berkeley.edu
Facility Name
Lake County Behavioral Health Services
City
Lucerne
State/Province
California
ZIP/Postal Code
95458
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Emma Agnew, MSW
Phone
510-643-3797
Email
emmagnew@berkeley.edu
Facility Name
Alameda County Behavioral Health Care Services
City
Oakland
State/Province
California
ZIP/Postal Code
94606
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Emma Agnew, MSW
Phone
510-643-3797
Email
emmagnew@berkeley.edu
Facility Name
Placer County Health and Human Services, Adult System of Care
City
Roseville
State/Province
California
ZIP/Postal Code
95678
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Emma Agnew, MSW
Phone
510-643-3797
Email
emmagnew@berkeley.edu
Facility Name
Monterey County Behavioral Health
City
Salinas
State/Province
California
ZIP/Postal Code
93906
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Emma Agnew, MSW
Phone
510-643-3797
Email
emmagnew@berkeley.edu
Facility Name
Bay Area Community Health
City
San Jose
State/Province
California
ZIP/Postal Code
95148
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Emma Agnew, MSW
Phone
510-643-3797
Email
emmagnew@berkeley.edu
Facility Name
County of Santa Cruz Behavioral Health Services for Children and Adults
City
Santa Cruz
State/Province
California
ZIP/Postal Code
95060
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Emma Agnew, MSW
Phone
510-643-3797
Email
emmagnew@berkeley.edu

12. IPD Sharing Statement

Learn more about this trial

Implementing and Sustaining a Sleep Treatment to Improve Community Mental Health Part 2: Train-the-Trainer

We'll reach out to this number within 24 hrs